Company Filing History:
Years Active: 2004
Title: Margrit Kernbach Hahn: Innovator in Monoclonal Antibodies
Introduction
Margrit Kernbach Hahn is a notable inventor based in Kaltenkirchen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for the prevention and treatment of diseases associated with the human Mcm3 protein.
Latest Patents
Margrit holds a patent for "Monoclonal antibodies against human protein Mcm3, process for their production, and their use." This invention relates to monoclonal antibodies that specifically detect and bind to the human Mcm3 protein. The patent outlines hybridoma cell lines that produce these antibodies, as well as the procedures for their production. The antibodies have potential applications in pharmaceutical compositions for treating diseases linked to Mcm3 expression.
Career Highlights
Margrit is associated with Dakocytomation Denmark A/S, where she has been involved in groundbreaking research. Her expertise in immunobiochemical methods has been instrumental in advancing the understanding of monoclonal antibodies. She has successfully navigated the complexities of antibody production and application in medical science.
Collaborations
Throughout her career, Margrit has collaborated with esteemed colleagues such as Johannes Gerdes and Thomas Scholzen. These partnerships have fostered innovation and have contributed to the successful development of her patented technologies.
Conclusion
Margrit Kernbach Hahn's work in monoclonal antibodies represents a significant advancement in biotechnology. Her contributions have the potential to impact the treatment of various diseases, showcasing the importance of innovation in the medical field.